Insulin Supplier-Buyer Network — Trade Flow Analysis

Name: Insulin Supplier-Buyer Trade Network Dataset — 188+ Indian Exporters, 14+ Importers, 111+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Insulin supplier network, Insulin buyers, pharmaceutical export India, Insulin trade data

TransData Nexus

Insulin

India Pharmaceutical Trade Intelligence

$76.0M188 Suppliers111 CountriesHS 30043110

ExportsIndia → THAILAND28.6%India → MEXICO19.2%

ImportsDENMARK → India$358.7B BRAZIL → India$149.3B

#1 Supplier: WOCKHARDT LIMITED

Who Supplies Insulin? Top Manufacturers & Buyers 2026 — WOCKHARDT LIMITED Leads | TransData Nexus | TransData Nexus

1WOCKHARDT LIMITED

WOCKHARDT LIMITED is the first-largest Insulin exporter from India, with a market share of 16.4% and a total export value of $12.5M across 454 shipments. Their average shipment value of $27.5K is below the market average of $30.0K, reflecting a high-volume, competitive pricing strategy.

WOCKHARDT LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• BERLIN PHARMACEUTICALS INDUSTRY CO, — $4.9M across 178 shipments (39.2% of this supplier's total exports)

• BERLIN PHARMACEUTICALS INDUSTRY CO, — $2.7M across 99 shipments (21.7% of this supplier's total exports)

• AYUSH PHARMA S A DE C V — $2.2M across 80 shipments (17.5% of this supplier's total exports)

• PHARMARIS PERU S.A.C. — $1.5M across 54 shipments (11.8% of this supplier's total exports)

• SISTEMAS AEREOS SA DE — $1.2M across 44 shipments (9.7% of this supplier's total exports)

Key Insight: WOCKHARDT LIMITED operates with high shipment frequency (454 shipments) at a per-shipment value of $27.5K, indicating a broad distribution network with many smaller, regular orders.

2M. J. BIOPHARM PRIVATE LIMITED

M. J. BIOPHARM PRIVATE LIMITED is the second-largest Insulin exporter from India, with a market share of 12.3% and a total export value of $9.3M across 303 shipments. Their average shipment value of $30.9K is above the market average of $30.0K, suggesting premium or bulk contract pricing.

M. J. BIOPHARM PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• COMMERCIAL BANK OF ETHIOPIA — $3.0M across 98 shipments (32.5% of this supplier's total exports)

• BJC HEALTHCARE COMPANY LIMITED — $3.0M across 96 shipments (31.7% of this supplier's total exports)

• DIABETIKA SRL — $1.9M across 62 shipments (20.4% of this supplier's total exports)

• BANK OF CEYLON — $833.0K across 27 shipments (8.9% of this supplier's total exports)

• TOTHE MAURITIUS COMM — $609.3K across 20 shipments (6.5% of this supplier's total exports)

Key Insight: M. J. BIOPHARM PRIVATE LIMITED's per-shipment value of $30.9K is 3% above the market average of $30.0K, consistent with large-order contracts or value-added formulations.

3M J BIOPHARM PRIVATE LIMITED

M J BIOPHARM PRIVATE LIMITED is the third-largest Insulin exporter from India, with a market share of 7.0% and a total export value of $5.3M across 75 shipments. Their average shipment value of $70.9K is above the market average of $30.0K, suggesting premium or bulk contract pricing.

M J BIOPHARM PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• COMMERCIAL BANK OF ETHIOPIA — $1.9M across 26 shipments (35.2% of this supplier's total exports)

• BANK OF CEYLON — $1.2M across 17 shipments (22.9% of this supplier's total exports)

• BJC HEALTHCARE COMPANY LIMITED — $1.1M across 16 shipments (20.9% of this supplier's total exports)

• BIOCOM LIMITED — $628.2K across 9 shipments (11.8% of this supplier's total exports)

• DIABETIKA SRL — $489.7K across 7 shipments (9.2% of this supplier's total exports)

Key Insight: M J BIOPHARM PRIVATE LIMITED's per-shipment value of $70.9K is 136% above the market average of $30.0K, consistent with large-order contracts or value-added formulations.

4GLAND PHARMA LTD

GLAND PHARMA LTD is the fourth-largest Insulin exporter from India, with a market share of 6.3% and a total export value of $4.8M across 81 shipments. Their average shipment value of $59.1K is above the market average of $30.0K, suggesting premium or bulk contract pricing.

GLAND PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• ELI LILLY PAKISTAN (PRIVATE) LTD — $1.7M across 28 shipments (35.0% of this supplier's total exports)

• ELI LILLY PAKISTAN (PRIVATE) LTD — $1.6M across 26 shipments (32.6% of this supplier's total exports)

• LILLY KOREA LTD — $647.9K across 11 shipments (13.5% of this supplier's total exports)

• ELI LILLY PAKISTAN (PRIVATE) LTD — $477.4K across 8 shipments (10.0% of this supplier's total exports)

• ELI LILLY PAKISTAN (PRIVATE) LTD — $428.4K across 7 shipments (9.0% of this supplier's total exports)

Key Insight: GLAND PHARMA LTD's per-shipment value of $59.1K is 97% above the market average of $30.0K, consistent with large-order contracts or value-added formulations.

5ORBIT LIFESCIENCE PVT. LTD.

ORBIT LIFESCIENCE PVT. LTD. is the fifth-largest Insulin exporter from India, with a market share of 2.2% and a total export value of $1.7M across 4 shipments. Their average shipment value of $420.1K is above the market average of $30.0K, suggesting premium or bulk contract pricing.

ORBIT LIFESCIENCE PVT. LTD. serves 1 named buyer in our database. INNODRIVE GROUP S.A DE CV is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• INNODRIVE GROUP S.A DE CV — $1.7M across 4 shipments (100.0% of this supplier's total exports)

Key Insight: ORBIT LIFESCIENCE PVT. LTD.'s per-shipment value of $420.1K is 1299% above the market average of $30.0K, consistent with large-order contracts or value-added formulations.

6ANGEL BIOGENICS PRIVATE LIMITED

ANGEL BIOGENICS PRIVATE LIMITED is the fifth-largest Insulin exporter from India, with a market share of 1.4% and a total export value of $1.1M across 47 shipments. Their average shipment value of $22.8K is below the market average of $30.0K, reflecting a high-volume, competitive pricing strategy.

ANGEL BIOGENICS PRIVATE LIMITED serves 4 named buyers in our database. NA is the dominant customer, accounting for 60.8% of this supplier's tracked business. Top customers include:

• NA — $653.1K across 29 shipments (60.8% of this supplier's total exports)

• TO THE ORDER — $403.8K across 18 shipments (37.6% of this supplier's total exports)

• LILONGWE MALAWI — $16.0K across 1 shipments (1.5% of this supplier's total exports)

• To The Order — $1.0K across 0 shipments (0.1% of this supplier's total exports)

Key Insight: ANGEL BIOGENICS PRIVATE LIMITED operates with high shipment frequency (47 shipments) at a per-shipment value of $22.8K, indicating a broad distribution network with many smaller, regular orders.

1Thailand

Thailand ranks as the first-largest destination for Insulin imports from India, with a total trade value of $21.7M across 339 shipments — representing a 28.6% share of all Insulin exports. The average shipment value of $64.1K is above the global average of $30.0K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Insulin importers in Thailand: BERLIN PHARMACEUTICALS INDUSTRY CO. is the largest buyer, accounting for 28.6% ($6.2M) of this market's total imports.

• BERLIN PHARMACEUTICALS INDUSTRY CO. — $6.2M (28.6% of Thailand's total)

• BJC HEALTHCARE COMPANY LIMITED — $6.1M (28.0% of Thailand's total)

• BERLIN PHARMACEUTICALS INDUSTRY CO — $5.2M (23.9% of Thailand's total)

Key Insight: Thailand's per-shipment average of $64.1K (114% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Thailand is a key market for Insulin imports from India.

Primary Market

Secondary Market

2Mexico

Mexico ranks as the second-largest destination for Insulin imports from India, with a total trade value of $14.6M across 31 shipments — representing a 19.2% share of all Insulin exports. The average shipment value of $472.0K is above the global average of $30.0K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.

Named Insulin importers in Mexico: AYUSH PHARMA S.A DE C.V. is the largest buyer, accounting for 52.4% ($7.7M) of this market's total imports.

• AYUSH PHARMA S.A DE C.V. — $7.7M (52.4% of Mexico's total)

• AYUSH PHARMA S A DE C V — $2.2M (14.9% of Mexico's total)

• INNODRIVE GROUP S.A DE CV — $2.0M (13.9% of Mexico's total)

Key Insight: Mexico's per-shipment average of $472.0K (1472% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Mexico is a key market for Insulin imports from India.

Primary Market

Secondary Market

3Ethiopia

Ethiopia ranks as the third-largest destination for Insulin imports from India, with a total trade value of $5.0M across 13 shipments — representing a 6.5% share of all Insulin exports. The average shipment value of $382.2K is above the global average of $30.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Insulin importers in Ethiopia: COMMERCIAL BANK OF ETHIOPIA is the largest buyer, accounting for 98.8% ($4.9M) of this market's total imports.

• COMMERCIAL BANK OF ETHIOPIA — $4.9M (98.8% of Ethiopia's total)

Key Insight: Ethiopia's per-shipment average of $382.2K (1173% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Ethiopia is a key market for Insulin imports from India.

Primary Market

Secondary Market

4Pakistan

Pakistan ranks as the fourth-largest destination for Insulin imports from India, with a total trade value of $4.5M across 59 shipments — representing a 6.0% share of all Insulin exports. The average shipment value of $77.1K is above the global average of $30.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Insulin importers in Pakistan: ELI LILLY PAKISTAN (PVT ) LTD is the largest buyer, accounting for 36.8% ($1.7M) of this market's total imports.

• ELI LILLY PAKISTAN (PVT ) LTD — $1.7M (36.8% of Pakistan's total)

• ELI LILLY PAKISTAN (PRIVATE) LTD — $1.6M (34.3% of Pakistan's total)

Key Insight: Pakistan's per-shipment average of $77.1K (157% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Pakistan is a key market for Insulin imports from India.

Primary Market

Secondary Market

5Dominican Republic

Dominican Republic ranks as the fifth-largest destination for Insulin imports from India, with a total trade value of $3.1M across 36 shipments — representing a 4.1% share of all Insulin exports. The average shipment value of $86.7K is above the global average of $30.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Insulin importers in Dominican Republic: DIABETIKA SRL is the largest buyer, accounting for 76.7% ($2.4M) of this market's total imports.

• DIABETIKA SRL — $2.4M (76.7% of Dominican Republic's total)

Key Insight: Dominican Republic's per-shipment average of $86.7K (189% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Dominican Republic is a key market for Insulin imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Insulin.
2.Flow Mapping: 188 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,532 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 111 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2,532 Verified Shipments

188 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Insulin

Insulin

Who Supplies Insulin? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Insulin — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Insulin? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Insulin Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1WOCKHARDT LIMITED

2M. J. BIOPHARM PRIVATE LIMITED

3M J BIOPHARM PRIVATE LIMITED

4GLAND PHARMA LTD

5ORBIT LIFESCIENCE PVT. LTD.

6ANGEL BIOGENICS PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Insulin Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Insulin Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Thailand

2Mexico

3Ethiopia

4Pakistan

5Dominican Republic

People Also Ask — Insulin Supplier & Trade Network

Insulin Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology